Gilead Sciences Inc (GILD) EVP,Corp Affairs & Gen Counsel Brett A Pletcher Sold $740,058 of Shares

Author's Avatar
Mar 04, 2020
Article's Main Image

EVP,Corp Affairs & Gen Counsel of Gilead Sciences Inc (30-Year Financial, Insider Trades) Brett A Pletcher (insider trades) sold 10,441 shares of GILD on 03/02/2020 at an average price of $70.88 a share. The total sale was $740,058.

Gilead Sciences Inc is a biopharmaceutical company that discovers, develops and commercializes new medicines in areas of unmet medical need. Its products target a number of areas, such as HIV, liver diseases, cardiovascular and other diseases. Gilead Sciences Inc has a market cap of $93.77 billion; its shares were traded at around $74.21 with a P/E ratio of 17.63 and P/S ratio of 4.22. The dividend yield of Gilead Sciences Inc stocks is 3.42%. Gilead Sciences Inc had annual average EBITDA growth of 19.50% over the past ten years. GuruFocus has detected 3 severe warning signs with Gilead Sciences Inc. .

Directors and Officers Recent Trades:

  • EVP,Corp Affairs & Gen Counsel Brett A Pletcher sold 10,441 shares of GILD stock on 03/02/2020 at the average price of $70.88. The price of the stock has increased by 4.7% since.
  • Director Gayle E Wilson sold 21,720 shares of GILD stock on 02/10/2020 at the average price of $67.72. The price of the stock has increased by 9.58% since.
  • EVP,Corp Affairs & Gen Counsel Brett A Pletcher sold 2,950 shares of GILD stock on 02/10/2020 at the average price of $69.32. The price of the stock has increased by 7.05% since.
  • EVP,Corp Affairs & Gen Counsel Brett A Pletcher sold 6,426 shares of GILD stock on 02/07/2020 at the average price of $68.58. The price of the stock has increased by 8.21% since.
  • Director Olsen Per Wold sold 42,002 shares of GILD stock on 02/07/2020 at the average price of $68.55. The price of the stock has increased by 8.26% since.

For the complete insider trading history of GILD, click here

.